CMS transparency rules and AI could bring “Expedia-like” drug price comparisons for consumers, but payer compliance to transparency rules remains low.
News|Articles|November 22, 2021
Sagent Recalls Four Lots of Levetiracetam
The antiseizure medication affected by the recall could have sterility issues.
Advertisement
Sagent Pharmaceuticals
The recall is because of a lack of container closure integrity, which could lead to sterility issues. To date, Sagent has not received reports of any product complaints or adverse events associated with this issue.
The NDC number of the affected product is 25021-780-05. The lot numbers included in the recall include:
- B0G85VB, with an expiration date of June 2022
- B0K88VA, with an expiration date of September 2022
- B0K89VA, with an expiration date of September 2022
- B1G194A, with an expiration date of June 2023
Advertisement
Related to this article
A new Spherix Global Insights survey shows providers want administrative support for prior authorization while patients prioritize access and affordability
Pharmacy benefit managers are moving beyond formulary access to provide support programs for women's health. Here's how three PBMs — Judi Health, LucyRx and RxPreferred — are putting that strategy into practice.
Women face more gaps in healthcare than men, from missed screenings, undertreatment and biased coverage. PBMs are launching programs to address some of the gaps.
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Texas A&M researchers discover promising therapy for fatty liver disease
2
Heather Burrell Ward, M.D., on personalizing TMS in schizophrenia
3
Low birth volume, finances tied to hospital obstetric unit closures
4
The hidden costs of routine radiology and how they can be addressed
5